Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity
In a recent study published in Nature Medicine, researchers evaluated rational combination treatment regimens for advanced/metastatic non-small-cell lung…
Read More